NCT04770389View on ClinicalTrials.gov

Randomized Study of Obicetrapib in Combination With Ezetimibe

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

May 7, 2021

Study Completion Date

June 30, 2021

Conditions
DyslipidemiasHigh CholesterolHypercholesterolemia
Interventions
DRUG

Obicetrapib 5mg

tablet

DRUG

Ezetimibe 10mg

tablet

OTHER

Placebo

tablet

Trial Locations (9)

60201

Evanston Premier Healthcare Research LLC, Evanston

77054

Juno Research, LLC - Medical Center Office, Houston

95648

Clinical Trials Research, Lincoln

3037 AN

Huisartsen Praktijk A.M.N. Zijtregto, Rotterdam

3067 GJ

Huisartsen Praktijk van Soerland, Rotterdam

2565 KN

Medisch Centrum Thomsonplein, The Hague

2572 GM

Huisartsen Praktijk Rambharose, The Hague

3333 GZ

Huisartsen Praktijk Broekman, Zwijndrecht

3334 SB

Dokters van Nederhoven, Zwijndrecht

Sponsors
All Listed Sponsors
lead

NewAmsterdam Pharma

INDUSTRY

NCT04770389 - Randomized Study of Obicetrapib in Combination With Ezetimibe | Biotech Hunter | Biotech Hunter